Delivery Order SPE2DB24D3015-SPE2DB25FFZTR

Award Date 6/11/25
Potential Completion Date 7/3/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,082.67 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR, a medication, with a period of performance through July 10, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a $3,082.67 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR, a specialty medication, to support military healthcare programs. The contract has an ultimate completion date of April 23, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a $3,082.67 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a specialty medication. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a $9,975.58 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR ML, a pharmaceutical product, with a performance period through June 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
This is a $3,082.67 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML autoinjector medication and has an ultimate completion date of March 5, 2025. The contract is not designated as a set-aside and was awarded under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a $3,082.67 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR, a specialty medication, to support medical needs of U.S. military personnel, veterans, and other federal beneficiaries. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a $21,559.88 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTOR, a medication, to support military healthcare programs. The contract has a completion date of February 4, 2025 and was awarded on January 13, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,987.78, is for the supply of 4,568,075,961 units of the medication BENLYSTA 200 MG/ML AUTOINJECTML. The contract has a period of performance through May 20, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a $39,902.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide BENLYSTA 200 MG/ML AUTOINJECTML. The contract has an ultimate completion date of June 13, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle to supply a wide range of...
This is a $4,987.78 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML AUTOINJECTML. The contract has an ultimate completion date of June 3, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime contractor on this award, which is a task order under the company's larger $999,999,999.00 Indefinite Delivery...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB25FFZTR
    Delivery Order

This is a $3,082.67 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BENLYSTA 200 MG/ML AUTOINJECTML, a medication, with a period of performance through July 3, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs.

Generated 9/14/25, 1:03 AM